These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22268601)

  • 1. Formulation and process design for a solid dosage form containing a spray-dried amorphous dispersion of ibipinabant.
    Leane MM; Sinclair W; Qian F; Haddadin R; Brown A; Tobyn M; Dennis AB
    Pharm Dev Technol; 2013; 18(2):359-66. PubMed ID: 22268601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
    Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
    AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barrier coated drug layered particles for enhanced performance of amorphous solid dispersion dosage form.
    Puri V; Dantuluri AK; Bansal AK
    J Pharm Sci; 2012 Jan; 101(1):342-53. PubMed ID: 21935949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS; Shimpi SL; Paradkar AR
    Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical stability and recrystallization kinetics of amorphous ibipinabant drug product by fourier transform raman spectroscopy.
    Sinclair W; Leane M; Clarke G; Dennis A; Tobyn M; Timmins P
    J Pharm Sci; 2011 Nov; 100(11):4687-99. PubMed ID: 21681752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of tablet formulation based on solid dispersion of glimepiride and poly(ester amide) hyperbranched polymer.
    Reven S; Homar M; Peternel L; Kristl J; Žagar E
    Pharm Dev Technol; 2013; 18(2):323-32. PubMed ID: 21812524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of highly compressible Ceolus™ microcrystalline cellulose for improved dosage form properties containing a hydrophilic solid dispersion.
    Dinunzio JC; Schilling SU; Coney AW; Hughey JR; Kaneko N; McGinity JW
    Drug Dev Ind Pharm; 2012 Feb; 38(2):180-9. PubMed ID: 21774741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Spray-Dried Dispersions in Early Pharmaceutical Development: Theoretical and Practical Challenges.
    Li J; Patel D; Wang G
    AAPS J; 2017 Mar; 19(2):321-333. PubMed ID: 27896684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detrimental Effect of the Film Coat Chemistry and Thickness on the Physical Stability of Amorphous Solid Dispersions in Tablet Formulations.
    Punia A; Biyyala V; Faassen F; Ash J; Lamm MS
    J Pharm Sci; 2023 Mar; 112(3):708-717. PubMed ID: 36189478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
    Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
    J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of silicified microcrystalline cellulose (Prosolv) as a polymer carrier of Epilobium parviflorum Schreb. extract in oral solid drug form.
    Marczyński Z; Zgoda MM; Jambor J
    Polim Med; 2007; 37(2):21-32. PubMed ID: 17957946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of rapidly disintegrating tablets containing itraconazole solid dispersions.
    Oshima T; Sonoda R; Ohkuma M; Sunada H
    Chem Pharm Bull (Tokyo); 2007 Nov; 55(11):1557-62. PubMed ID: 17978511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced Physical Stability of Amorphous Drug Formulations via Dry Polymer Coating.
    Capece M; Davé R
    J Pharm Sci; 2015 Jun; 104(6):2076-2084. PubMed ID: 25902736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid state drug-polymer miscibility studies using the model drug ABT-102.
    Jog R; Gokhale R; Burgess DJ
    Int J Pharm; 2016 Jul; 509(1-2):285-295. PubMed ID: 27265312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
    McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
    Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY; Lin KH; Li MJ
    J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QbD approach to downstream processing of spray-dried amorphous solid dispersions - a case study.
    Henriques J; Moreira J; Doktorovová S
    Pharm Dev Technol; 2021 Mar; 26(3):269-277. PubMed ID: 33322990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Temperature and Moisture on the Physical Stability of Binary and Ternary Amorphous Solid Dispersions of Celecoxib.
    Xie T; Taylor LS
    J Pharm Sci; 2017 Jan; 106(1):100-110. PubMed ID: 27476771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elucidation of Compression-Induced Surface Crystallization in Amorphous Tablets Using Sum Frequency Generation (SFG) Microscopy.
    Mah PT; Novakovic D; Saarinen J; Van Landeghem S; Peltonen L; Laaksonen T; Isomäki A; Strachan CJ
    Pharm Res; 2017 May; 34(5):957-970. PubMed ID: 27738954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches to Understanding the Solution-State Organization of Spray-Dried Dispersion Feed Solutions and Its Translation to the Solid State.
    Defrese MK; Farmer MA; Long Y; Timmerman LR; Bae Y; Marsac PJ
    Mol Pharm; 2020 Dec; 17(12):4548-4563. PubMed ID: 32965120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.